Günther Bernhardt

4.5k total citations
143 papers, 3.8k citations indexed

About

Günther Bernhardt is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Günther Bernhardt has authored 143 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Molecular Biology, 50 papers in Cellular and Molecular Neuroscience and 47 papers in Oncology. Recurrent topics in Günther Bernhardt's work include Receptor Mechanisms and Signaling (55 papers), Neuropeptides and Animal Physiology (45 papers) and Chemical Synthesis and Analysis (26 papers). Günther Bernhardt is often cited by papers focused on Receptor Mechanisms and Signaling (55 papers), Neuropeptides and Animal Physiology (45 papers) and Chemical Synthesis and Analysis (26 papers). Günther Bernhardt collaborates with scholars based in Germany, Japan and Austria. Günther Bernhardt's co-authors include Armin Buschauer, Thilo Spruß, Max Keller, Gert Fricker, Stefan Dove, Henri Brunner, Christian Lottner, Burkhard König, Harald Gschaidmeier and David S. Miller and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Günther Bernhardt

143 papers receiving 3.7k citations

Peers

Countries citing papers authored by Günther Bernhardt

Since Specialization

Citations

This map shows the geographic impact of Günther Bernhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günther Bernhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günther Bernhardt more than expected).

Fields of papers citing papers by Günther Bernhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günther Bernhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günther Bernhardt. The network helps show where Günther Bernhardt may publish in the future.

Co-authorship network of co-authors of Günther Bernhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Günther Bernhardt. A scholar is included among the top collaborators of Günther Bernhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günther Bernhardt. Günther Bernhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Dynamic, Split-Luciferase-Based Mini-G Protein Sensor to Functionally Characterize Ligands at All Four Histamine Receptor Subtypes 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Lukas Grätz, (unknown), (unknown), Günther Bernhardt, Steffen Pockes, Andrea Straßer	19
2	Red-Emitting Dibenzodiazepinone Derivatives as Fluorescent Dualsteric Probes for the Muscarinic Acetylcholine M₂ Receptor 2020 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), David Wifling, (unknown), Harald Hübner, (unknown), (unknown), Günther Bernhardt, Peter Gmeiner, Nicholas D. Holliday, Max Keller	13
3	Conjugation of Short Peptides to Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Determines M₂R Selectivity 2019 ·Journal of Medicinal Chemistry ·(unknown), David Wifling, (unknown), (unknown), Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	10
4	Fluorescence Labeling of Neurotensin(8–13) via Arginine Residues Gives Molecular Tools with High Receptor Affinity 2019 ·ACS Medicinal Chemistry Letters ·Max Keller, (unknown), (unknown), (unknown), Lisa Schindler, Timo Littmann, (unknown), Harald Hübner, Günther Bernhardt, Peter Gmeiner, Nicholas D. Holliday	20
5	Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M₂R Affinity and Selectivity 2017 ·ACS Omega ·(unknown), (unknown), Judith Mayr, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	17
6	Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M₂ Muscarinic Acetylcholine Receptor 2017 ·Journal of Medicinal Chemistry ·(unknown), (unknown), David Wifling, Harald Hübner, Günther Bernhardt, Peter Gmeiner, Max Keller	20
7	Flavonoid derivatives as selective ABCC1 modulators: Synthesis and functional characterization 2015 ·European Journal of Medicinal Chemistry ·(unknown), Qiu Sun, Günther Bernhardt, Burkhard König, Armin Buschauer	34
8	Qualitative and quantitative analysis of hyaluronan oligosaccharides with high performance thin layer chromatography using reagent-free derivatization on amino-modified silica and electrospray ionization-quadrupole time-of-flight mass spectrometry coupling on normal phase 2012 ·Journal of Chromatography A ·(unknown), (unknown), Günther Bernhardt, Jörg Heilmann, Armin Buschauer	12
9	Functional reconstitution of human neuropeptide Y (NPY) Y₂and Y₄receptors in Sf9 insect cells 2011 ·Journal of Receptors and Signal Transduction ·(unknown), (unknown), (unknown), Chiara Cabrele, Günther Bernhardt, Roland Seifert, Armin Buschauer	10
10	Fast counter-electroosmotic capillary electrophoresis–time-of-flight mass spectrometry of hyaluronan oligosaccharides 2011 ·Analytical and Bioanalytical Chemistry ·(unknown), (unknown), Günther Bernhardt, Armin Buschauer, Frank‐Michael Matysik	21
11	Recombinant human hyaluronidase Hyal-1: insect cells versus Escherichia coli as expression system and identification of low molecular weight inhibitors + 2007 ·Glycobiology ·(unknown), (unknown), (unknown), Günther Bernhardt, Rainer Rudolph, Armin Buschauer	38
12	[1, 2‐Bis(2, 6‐difluoro‐3‐hydroxyphenyl)ethylene‐diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer ‐ Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level 2004 ·Archiv der Pharmazie ·(unknown), Rolf W. Hartmann, Christine Batzl‐Hartmann, Günther Bernhardt, Thilo Spruß, Karin Beckenlehner, Marion Koch, (unknown), (unknown), Ronald Gust, Helmut Schönenberger	8
13	Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo 2002 ·Journal of Clinical Investigation ·(unknown), Björn Bauer, David S. Miller, (unknown), (unknown), Thilo Spruß, Günther Bernhardt, (unknown), Lothar Färber, Harald Gschaidmeier, Armin Buschauer, Gert Fricker	25
14	Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo 2002 ·Journal of Clinical Investigation ·(unknown), Björn Bauer, David S. Miller, (unknown), (unknown), Thilo Spruß, Günther Bernhardt, (unknown), Lothar Färber, Harald Gschaidmeier, Armin Buschauer, Gert Fricker	283
15	1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes — New Biological Response Modifiers for the Therapy of Breast Cancer. Synthesis and Evaluation of Estrogenic/Antiestrogenic Properties 2001 ·Archiv der Pharmazie ·(unknown), Rolf W. Hartmann, Christine Batzl‐Hartmann, (unknown), Thilo Spruß, Günther Bernhardt, Ronald Gust, Helmut Schönenberger	10
16	Part 1: The MXT-M-3.2 Breast Cancer Stimulates the Growth of an Identical Second Graft; [Meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) Inhibits this Process 2000 ·Archiv der Pharmazie ·(unknown), Thilo Spruß, Günther Bernhardt, Helmut Schönenberger	6
17	Efficient Transfection of Human Endometrial Cancer (HEC-1B) Cells with FuGENE^TM 6 Transfection Reagent 1999 ·University of Regensburg Publication Server (University of Regensburg) ·(unknown), Günther Bernhardt, Armin Buschauer	1
18	Stereochemical Investigations on Intermediates for the Synthesis of Histamine H_2 Receptor Agonists and Neuropeptide Y Y_1 Antagonists: Chiral Separation of Phenyl(pyridyl)alkanoic Acids by HPLC and CE 1998 ·University of Regensburg Publication Server (University of Regensburg) ·Andreas Schuster, (unknown), (unknown), (unknown), (unknown), Günther Bernhardt, Armin Buschauer	1
19	[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer 1992 ·Journal of Cancer Research and Clinical Oncology ·Günther Bernhardt, Ronald Gust, Herta Reile, (unknown), Richard Müller, (unknown), Thilo Spruß, Helmut Schönenberger, Thomas Burgemeister, Albrecht Mannschreck, Klaus‐Jürgen Range, Ulrich Klement	8
20	[1,2-Bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancer 1992 ·Journal of Cancer Research and Clinical Oncology ·Günther Bernhardt, Ronald Gust, Herta Reile, (unknown), Richard Müller, (unknown), Thilo Spruß, Helmut Schönenberger, Thomas Burgemeister, Albrecht Mannschreck, (unknown), Ulrich Klement	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact